Navigation Links
Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises
Date:5/23/2013

eamless connectivity—directly into your hearing aid(s) at volumes that are just right for you—from your smartphone, iPod, television, and other beloved high-tech gadgets. What's more, you own the volume. No one around you needs to be affected.

(5)   They're always at the ready. A new rechargeable feature on some newly designed hearing aids allows you to recharge your hearing aids every night, so they're ready, ramped up, and waiting for you in the morning. There's no more fumbling with small batteries. Just place the hearing aids into the charger at night, and they're ready to go in the morning.

For a step-by-step breakdown of what to expect, ask, and look for when visiting a hearing healthcare professional and purchasing a hearing aid, download Your Guide to Buying Hearing Aids at www.BetterHearing.org, under publications.

Media Contact: 
Better Hearing Institute (BHI) 
Fabia@BetterHearing.org

 

 


'/>"/>
SOURCE Better Hearing Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADL Data Systems Partners With COMS Interactive, LLC
2. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
3. Pharmagen Laboratories Remains Industry Leader on Patient Safety
4. Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
5. While Half of Facial Injectable Patients Request A Specific Product, Most Still Remain Unaware of Many Brands
6. Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
7. Life Technologies to Help Identify up to 20,000 Human Remains Found in Libyas Mass Graves
8. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
9. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
10. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
11. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... James M. Gower is retiring from the board ... executive officer, and Raul Rodriguez , most recently serving ... the position of chief executive officer and join the board ... Board of Directors since 2005, will become chairman. Mr. Gower ...
(Date:11/24/2014)... , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... Joseph Kim , President and CEO of Inovio Pharmaceuticals, will ... team to ring the Nasdaq Opening Bell tomorrow, Tuesday November ... September 15 th listing on the Nasdaq Global Select ... Dr. Kim said, "We are honored to ring the Nasdaq ...
(Date:11/22/2014)...  Sprout Pharmaceuticals today announced positive preliminary results from a ... flibanserin up to 200 mg at bedtime had no next-day ... 20 th Annual Fall Scientific Meeting of the Sexual ... Miami . The Phase 1 ... Letter and the Formal Dispute Resolution that was filed in ...
Breaking Medicine Technology:Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today ... 2) in gout patients initiating allopurinol therapy, ARCALYST (rilonacept) ... primary endpoint was the number of gout flares per ... ARCALYST at a weekly, self-administered, subcutaneous dose of either ...
... Feb. 28, 2011 Nile Therapeutics, Inc. (Nasdaq: ... development of novel therapeutics for cardiovascular disease, announced plans ... heart failure.  Nile plans to develop cenderitide (formerly CD-NP) ... decompensated heart failure (ADHF) patients continuously for up to ...
Cached Medicine Technology:ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 2ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 3ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 4ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 5ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 6ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 7ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 8ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 9ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy 10Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 2Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 3Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure 4
(Date:11/24/2014)... Longmont, CO, and Philadelphia, PA (PRWEB) November 24, ... a provider of care coordination and disease management ... organizations, has chosen to implement Essette’s Medical Management ... powerful new Essette SaaS platform in a program ... latest Essette suite includes Population Health Management, Care ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous ... promotion for many products, especially the beautiful colored wedding ... choice with amazing discounts, up to 90% off. Don’t ... is easy to buy colored wedding dresses in different ... also famous for delicate craftsmanship, elegant style and perfect ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... holidays can be a challenge for families of children ... an expert says. "Holidays with family can be ... have children with special needs, some care must be ... of the Sciences in Philadelphia, said in a university ... or visitors know what special requirements are needed to ...
Breaking Medicine News(10 mins):Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2
... By Madonna Behen HealthDay Reporter , WEDNESDAY, Jan. ... killer in the world, and only about 15 percent of ... treatable. But two preliminary studies that are scheduled to ... scientists are moving closer to developing new screening tests that ...
... available in Spanish . , Let us assume ... GP is not sure what is wrong, and notes down on ... questions have been answered, the screen shows what the disease could ... to see such-and-such a specialist. Today this is utopia, but the ...
... lower risk of developing Type 2 diabetes, a disease on ... health problems? Scientists are offering a new solution to that ... Agricultural & Food Chemistry . Ling Zheng, Kun Huang ... are at a lower risk for developing Type 2 diabetes, ...
... fast-tracked through hospital emergency departments and operated on within ... developed by UK experts in anaesthesia, orthopaedics, geriatrics and ... Anaesthesia . However, patients in one ... longer than two days, risking lengthier inpatient stays, increased ...
... ,Surgeons aged 35 to 50 provide the safest care for ... about ongoing training and motivation of surgeons during their careers, ... France. They analyzed data from 3,574 thyroidectomies (removal of ... over a one-year period. The average age of the surgeons ...
... risks, but a new study shows that the consequences of ... function, according to a new study by University of Alabama ... of the Journal of the American Medical Association . ... in the United States, according to the National Survey on ...
Cached Medicine News:Health News:Tests Might Someday Help Spot Early Lung Cancer 2Health News:Tests Might Someday Help Spot Early Lung Cancer 3Health News:The keys to helping patients, on the GP's computer 2Health News:The keys to helping patients, on the GP's computer 3Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 2Health News:Hip fracture guidelines tackle 'considerable variations' in UK and Irish hospital care 3Health News:Surgeons in Mid-Career Have Fewest Complications: Study 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 3
The A350 test is used for POC testing in hospital emergency departments, replacing the need to draw blood for alcohol testing. Each hash mark is 0.02% or 20 mg/dL....
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Medicine Products: